+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Asthma Inhalers Market by Type (Dry Powder Inhaler, Metered-Dose Inhaler, Soft Mist Inhaler), Mode of Operation (Digitally Operated, Manually Operated), End-user, Distribution Channel - Forecast 2024-2030

  • PDF Icon

    Report

  • 185 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5715687
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Asthma Inhalers Market size was estimated at USD 2.16 billion in 2023, USD 2.46 billion in 2024, and is expected to grow at a CAGR of 14.48% to reach USD 5.57 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Asthma Inhalers Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Asthma Inhalers Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Asthma Inhalers Market, highlighting leading vendors and their innovative profiles. These include AMIKO Digital Health, Armstrong Pharmaceuticals, Inc., AstraZeneca PLC, Beximco Pharmaceuticals Ltd., Boehringer Ingelheim International GmbH, Cadila Healthcare Ltd., CHIESI Farmaceutici S.p.A., Cipla Limited, Cohero Health, Inc., GlaxoSmithKline PLC, H&T Presspart, HELTMAN Medikal A.S., Koninklijke Philips N.V., Luckys Pharma, Merck & Co., Inc., Microlife Corporation, Novartis AG, Nutra Respiro, Omron Corporation, OPKO Health, Inc., PARI GmbH, Pulmatrix, Inc., Sunovion Pharmaceuticals Inc. by Sumitomo Dainippon Pharma Co., Ltd., Teva Pharmaceutical Industries Ltd., and Ultratech India Ltd.

Market Segmentation & Coverage

This research report categorizes the Asthma Inhalers Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Dry Powder Inhaler
    • Metered-Dose Inhaler
      • Breath-Actuated Pressurized Metered-dose Inhalers
      • Metered-dose Inhaler with a Spacer
      • Standard Pressurized Metered-Dose Inhalers
    • Soft Mist Inhaler
  • Mode of Operation
    • Digitally Operated
    • Manually Operated
  • End-user
    • Homecare Facilities
    • Hospitals & Clinics
  • Distribution Channel
    • Offline
    • Online
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Asthma Inhalers Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Asthma Inhalers Market?
  3. What are the technology trends and regulatory frameworks in the Asthma Inhalers Market?
  4. What is the market share of the leading vendors in the Asthma Inhalers Market?
  5. Which modes and strategic moves are suitable for entering the Asthma Inhalers Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Asthma Inhalers Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of respiratory disorders globally
5.1.1.2. Rising adoption of digitally approved asthma inhalers
5.1.1.3. Government initiatives to stop respiratory disorders
5.1.2. Restraints
5.1.2.1. High cost of smart asthma inhalers
5.1.3. Opportunities
5.1.3.1. Technological advancements and development of novel asthma inhalers
5.1.3.2. Growing investment and R&D activities for development of asthma inhalers
5.1.4. Challenges
5.1.4.1. Certain problems associated with asthma inhalers
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Asthma Inhalers Market, by Type
6.1. Introduction
6.2. Dry Powder Inhaler
6.3. Metered-Dose Inhaler
6.4.1. Breath-Actuated Pressurized Metered-dose Inhalers
6.4.2. Metered-dose Inhaler with a Spacer
6.4.3. Standard Pressurized Metered-Dose Inhalers
6.4. Soft Mist Inhaler
7. Asthma Inhalers Market, by Mode of Operation
7.1. Introduction
7.2. Digitally Operated
7.3. Manually Operated
8. Asthma Inhalers Market, by End-user
8.1. Introduction
8.2. Homecare Facilities
8.3. Hospitals & Clinics
9. Asthma Inhalers Market, by Distribution Channel
9.1. Introduction
9.2. Offline
9.3. Online
10. Americas Asthma Inhalers Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Asthma Inhalers Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Asthma Inhalers Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. AMIKO Digital Health
14.1.2. Armstrong Pharmaceuticals, Inc.
14.1.3. AstraZeneca PLC
14.1.4. Beximco Pharmaceuticals Ltd.
14.1.5. Boehringer Ingelheim International GmbH
14.1.6. Cadila Healthcare Ltd.
14.1.7. CHIESI Farmaceutici S.p.A.
14.1.8. Cipla Limited
14.1.9. Cohero Health, Inc.
14.1.10. GlaxoSmithKline PLC
14.1.11. H&T Presspart
14.1.12. HELTMAN Medikal A.S.
14.1.13. Koninklijke Philips N.V.
14.1.14. Luckys Pharma
14.1.15. Merck & Co., Inc.
14.1.16. Microlife Corporation
14.1.17. Novartis AG
14.1.18. Nutra Respiro
14.1.19. Omron Corporation
14.1.20. OPKO Health, Inc.
14.1.21. PARI GmbH
14.1.22. Pulmatrix, Inc.
14.1.23. Sunovion Pharmaceuticals Inc. by Sumitomo Dainippon Pharma Co., Ltd.
14.1.24. Teva Pharmaceutical Industries Ltd.
14.1.25. Ultratech India Ltd.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. ASTHMA INHALERS MARKET RESEARCH PROCESS
FIGURE 2. ASTHMA INHALERS MARKET SIZE, 2023 VS 2030
FIGURE 3. ASTHMA INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. ASTHMA INHALERS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. ASTHMA INHALERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ASTHMA INHALERS MARKET DYNAMICS
FIGURE 7. ASTHMA INHALERS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. ASTHMA INHALERS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. ASTHMA INHALERS MARKET SIZE, BY MODE OF OPERATION, 2023 VS 2030 (%)
FIGURE 10. ASTHMA INHALERS MARKET SIZE, BY MODE OF OPERATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. ASTHMA INHALERS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. ASTHMA INHALERS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. ASTHMA INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 14. ASTHMA INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ASTHMA INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS ASTHMA INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ASTHMA INHALERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES ASTHMA INHALERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ASTHMA INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ASTHMA INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ASTHMA INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ASTHMA INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. ASTHMA INHALERS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. ASTHMA INHALERS MARKET SHARE, BY KEY PLAYER, 2023

Companies Mentioned

  • AMIKO Digital Health
  • Armstrong Pharmaceuticals, Inc.
  • AstraZeneca PLC
  • Beximco Pharmaceuticals Ltd.
  • Boehringer Ingelheim International GmbH
  • Cadila Healthcare Ltd.
  • CHIESI Farmaceutici S.p.A.
  • Cipla Limited
  • Cohero Health, Inc.
  • GlaxoSmithKline PLC
  • H&T Presspart
  • HELTMAN Medikal A.S.
  • Koninklijke Philips N.V.
  • Luckys Pharma
  • Merck & Co., Inc.
  • Microlife Corporation
  • Novartis AG
  • Nutra Respiro
  • Omron Corporation
  • OPKO Health, Inc.
  • PARI GmbH
  • Pulmatrix, Inc.
  • Sunovion Pharmaceuticals Inc. by Sumitomo Dainippon Pharma Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Ultratech India Ltd.

Methodology

Loading
LOADING...

Table Information